NCT00448240 2025-03-18
Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer
Henry Ford Health System
Phase 2/3 Terminated
Clinical Trials
6 trialsNCT02551458 2024-03-07
Esostrate
Centre Hospitalier Universitaire Dijon
Phase 2/3 Terminated
NCT01631357 2019-11-05
CIK
Tianjin Medical University Cancer Institute and Hospital
Phase 2/3 Completed
NCT01211938 2017-05-16
JANORL2
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2/3 Completed
NCT01761747 2014-12-23
Ponatinib for Squamous Cell Lung and Head and Neck Cancers
Dana-Farber Cancer Institute
Phase 2/3 Terminated
NCT00770393 2008-10-10
Laryngeal Preservation in Pyriform Sinus Carcinoma
Centre Hospitalier Universitaire de Saint Etienne
Phase 2/3 Completed